Clinical trial Recruiting at 1 site Interventional Ages 20 to 40 Women only

Mulligan mobilization with core and pelvic-floor strengthening for postpartum sacroiliac joint pain

Official title: Additional Effects of Mulligan Mobilization With Movement Along With Core Strengthening Exercises in Postpartum Females With Sacroiliac Joint Dysfunction

Run by Foundation University Islamabad · NCT07526038 · Data updated 2026-11-12

This study will see if adding Mulligan mobilization to core and pelvic‑floor strengthening helps postpartum women (6 weeks to 6 months after delivery) who have sacroiliac joint pain.

More Post Partum Depression trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexWomen only
Enrollment48 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad, Punjab Province)
StatusRecruiting
StartedMay 20, 2026
Main results expectedJuly 1, 2026
Study endsJuly 15, 2026
Registry record updatedMay 20, 2026
Trial IDNCT07526038 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are multiparous postpartum females aged 20–40, between 6 weeks and 6 months after delivery, who have at least three positive sacroiliac joint provocation tests.

Probably not a fit

Patients with pelvic fractures or recent pelvic surgery, neurological or rheumatologic disorders, or those unable to participate in active exercise or manual therapy are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Postpartum multiparous women aged 20–40 with sacroiliac joint dysfunction confirmed by at least three positive provocation tests will receive a program combining Mulligan mobilization with targeted core and pelvic‑floor strengthening. The intervention aims to correct subtle SIJ positional faults with manual therapy while improving pelvic stability and neuromuscular control through exercise. Participants will be followed to monitor changes in pain, function, and SIJ provocation test results. The approach targets common postpartum biomechanical and hormonal contributors to SIJ pain.

Why it matters

Potential benefit: If successful, the combined manual therapy and exercise program could reduce pain and improve pelvic stability and daily function for postpartum women with SIJ dysfunction.

How similar studies have gone: Some clinical reports and smaller trials support Mulligan mobilization and core strengthening for SIJ pain, but high‑quality evidence specifically in postpartum populations remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postpartum females(both normal delivery \& C-section) aged 20-40 years
* Parity level: Multiparous
* Duration: 6 weeks to 6 months postpartum
* At least three Positive SIJ provocation tests (e.g., stork test, compression, distraction, thigh thrust, Ganslen's and sacral thrust)

Exclusion Criteria:

* Pelvic fractures or recent surgery
* Neurological or rheumatologic disorders
* Inability to participate in active exercise or manual therapy due to medical or psychological reasons

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Punjab Province, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Rida Zainab, DPT — Foundation University Islamabad
  • Study coordinator: Rida Zainab, DPT
  • Email: doczaini786@gmail.com
  • Phone: 03045000297

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.